Pivotal Clinical SAHARA Study Shows Candesant Biomedical’s Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

SAHARA Meets Study Endpoints, Demonstrating Underarm Sweating Significantly Reduced Following Three-Minute In-Office Treatment NASHVILLE, Tenn., March 18, 2023 /PRNewswire/ — Candesant Biomedical (“Candesant”), a private medical device company focused on the development and…